Korean pharmas’ intensified reliability only on developing generic medicines

When it comes to the generic drug development, Korean pharmaceutical companies were analyzed to focus only on medicines with expired patents. This year, there were 625 medicines recognized by bioequivalent test, which the number was decreased by more than 50% compared to the last year.

Moreover, medicines which recognized by the most bioequivalence tests this year were generics referencing Don...